Circumventing cancer drug resistance in the era of personalized medicine
- PMID: 22585993
- DOI: 10.1158/2159-8290.CD-12-0012
Circumventing cancer drug resistance in the era of personalized medicine
Abstract
All successful cancer therapies are limited by the development of drug resistance. The increase in the understanding of the molecular and biochemical bases of drug efficacy has also facilitated studies elucidating the mechanism(s) of drug resistance. Experimental approaches that can help predict the eventual clinical drug resistance, coupled with the evolution of systematic genomic and proteomic technologies, are rapidly identifying novel resistance mechanisms. In this review, we provide a historical background on drug resistance and a framework for understanding the common ways by which cancers develop resistance to targeted therapies. We further discuss advantages and disadvantages of experimental strategies that can be used to identify drug resistance mechanism(s).
Significance: Increased knowledge of drug resistance mechanisms will aid in the development of effective therapies for patients with cancer. We provide a summary of current knowledge on drug resistance mechanisms and experimental strategies to identify and study additional drug resistance pathways.
©2012 AACR.
Similar articles
-
INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.Pac Symp Biocomput. 2016;21:45-56. Pac Symp Biocomput. 2016. PMID: 26776172
-
New tools for old drugs: Functional genetic screens to optimize current chemotherapy.Drug Resist Updat. 2018 Jan;36:30-46. doi: 10.1016/j.drup.2018.01.001. Epub 2018 Jan 12. Drug Resist Updat. 2018. PMID: 29499836 Free PMC article. Review.
-
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.Drug Resist Updat. 2015 Nov;23:20-54. doi: 10.1016/j.drup.2015.10.003. Epub 2015 Oct 31. Drug Resist Updat. 2015. PMID: 26690339 Review.
-
Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.Pharmacol Ther. 2016 Sep;165:79-92. doi: 10.1016/j.pharmthera.2016.05.007. Epub 2016 May 21. Pharmacol Ther. 2016. PMID: 27218886 Free PMC article. Review.
-
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics.Drug Resist Updat. 2016 Sep;28:65-81. doi: 10.1016/j.drup.2016.07.001. Epub 2016 Jul 16. Drug Resist Updat. 2016. PMID: 27620955 Review.
Cited by
-
Satureja bachtiarica Induces Cancer Cell Death in Breast and Glioblastoma Cancer in 2D/3D Models and Suppresses Breast Cancer Stem Cells.Cells. 2023 Nov 26;12(23):2713. doi: 10.3390/cells12232713. Cells. 2023. PMID: 38067141 Free PMC article.
-
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.EMBO Mol Med. 2012 Aug;4(8):675-84. doi: 10.1002/emmm.201101131. Epub 2012 Jun 25. EMBO Mol Med. 2012. PMID: 22733553 Free PMC article. Review.
-
Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment.Int J Mol Sci. 2016 Sep 14;17(9):1552. doi: 10.3390/ijms17091552. Int J Mol Sci. 2016. PMID: 27649156 Free PMC article. Review.
-
A simple gene set-based method accurately predicts the synergy of drug pairs.BMC Syst Biol. 2016 Aug 26;10 Suppl 3(Suppl 3):66. doi: 10.1186/s12918-016-0310-3. BMC Syst Biol. 2016. PMID: 27585722 Free PMC article.
-
Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer: Determining Optimal Dose Schedules by High-performance Computer Simulation.Cancer Res Commun. 2023 Jan 3;3(1):21-30. doi: 10.1158/2767-9764.crc-22-0271. Epub 2023 Jan 9. Cancer Res Commun. 2023. PMID: 36685168 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
